ASTANA, Kazakhstan, February 8. The Ministry of
Health of Kazakhstan has signed an investment agreement with the
Turkish pharmaceutical company Nobel to establish a new
pharmaceutical production facility in Kazakhstan, Trend reports via the
Ministry.


A total investment value amounts to 40 billion tenge (about
$79.4 million). The plant will produce 17 socially significant
drugs and 40 different types of pharmaceutical products.


The construction of the new plant is set to begin in 2026, with
production meeting international GMP (Good Manufacturing Practice)
standards.


Akmaral Alnazarova, the Minister of Health, emphasized during
the signing that the goal is to ensure the country has access to
high-quality and affordable medicines while also creating the
conditions for Kazakhstan to become a regional pharmaceutical hub.
She added that all necessary legislative frameworks for this
development have already been established.


This project is expected to strengthen Kazakhstan's
pharmaceutical security, expand its export potential, and create
new jobs, reinforcing the country's position as a pharmaceutical
production center in the region.







On January 29, 2026, during a government meeting, Alnazarova
reported that the government had approved a number of
pharmaceutical projects, which will result in the production of 400
new medicines in Kazakhstan over the next 2-4 years. To date, six
investment projects, with a total value of $620 million (316
billion tenge), have been approved. These new projects are expected
to create more than 1,000 jobs.


It was also noted that investments in the pharmaceutical sector
have doubled over the past two years, rising from $47 million to
$87 million.


As of mid-2025, Kazakhstan hosts 207 pharmaceutical
manufacturers, comprising 43 in medicine production and 164 in
medical devices. The industry features 25 domestic firms with Good
Manufacturing Practice (GMP) certifications, primarily in Shymkent,
Almaty, and Karaganda. Local producers offer around 900 medicines
and over 1,000 medical devices.


Nobel, founded in 1964, is a Turkish pharmaceutical company with
100% local capital.